Svas Biosana Past Earnings Performance

Past criteria checks 4/6

Svas Biosana has been growing earnings at an average annual rate of 22.7%, while the Medical Equipment industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 17.4% per year. Svas Biosana's return on equity is 9.3%, and it has net margins of 4.4%.

Key information

22.7%

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth8.3%
Revenue growth rate17.4%
Return on equity9.3%
Net Margin4.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Svas Biosana's (BIT:SVS) Earnings Are Weaker Than They Seem

May 10
Svas Biosana's (BIT:SVS) Earnings Are Weaker Than They Seem

We Think You Should Be Aware Of Some Concerning Factors In Svas Biosana's (BIT:SVS) Earnings

Oct 06
We Think You Should Be Aware Of Some Concerning Factors In Svas Biosana's (BIT:SVS) Earnings

Recent updates

Svas Biosana's (BIT:SVS) Earnings Are Weaker Than They Seem

May 10
Svas Biosana's (BIT:SVS) Earnings Are Weaker Than They Seem

The Returns At Svas Biosana (BIT:SVS) Aren't Growing

Dec 09
The Returns At Svas Biosana (BIT:SVS) Aren't Growing

We Think You Should Be Aware Of Some Concerning Factors In Svas Biosana's (BIT:SVS) Earnings

Oct 06
We Think You Should Be Aware Of Some Concerning Factors In Svas Biosana's (BIT:SVS) Earnings

Revenue & Expenses Breakdown

How Svas Biosana makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BIT:SVS Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241245190
31 Mar 241235190
31 Dec 231225190
30 Sep 231175190
30 Jun 231124190
31 Mar 231064180
31 Dec 221004180
30 Sep 22943150
30 Jun 22883120
31 Mar 22853110
31 Dec 21823110
30 Sep 21803150
30 Jun 21793190
31 Mar 21783150
31 Dec 20773120

Quality Earnings: SVS has a large one-off gain of €1.7M impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: SVS's current net profit margins (4.4%) are higher than last year (3.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SVS's earnings have grown significantly by 22.7% per year over the past 5 years.

Accelerating Growth: SVS's earnings growth over the past year (31.6%) exceeds its 5-year average (22.7% per year).

Earnings vs Industry: SVS earnings growth over the past year (31.6%) exceeded the Medical Equipment industry 26%.


Return on Equity

High ROE: SVS's Return on Equity (9.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:05
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Svas Biosana S.p.A. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simone MieliTPICAP Midcap
Mathias PaladinoTPICAP Midcap